84 related articles for article (PubMed ID: 7914829)
21. Relative roles of osteoclast colony-stimulating factor and macrophage colony-stimulating factor in the course of osteoclast development.
Lee TH; Fevold KL; Muguruma Y; Lottsfeldt JL; Lee MY
Exp Hematol; 1994 Jan; 22(1):66-73. PubMed ID: 8282061
[TBL] [Abstract][Full Text] [Related]
22. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
23. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
[TBL] [Abstract][Full Text] [Related]
24. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
[TBL] [Abstract][Full Text] [Related]
25. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
Van Overstraeten-Schlögel N; Beguin Y; Gothot A
Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
[TBL] [Abstract][Full Text] [Related]
26. Homogeneous interleukin 3 enhances arginase activity in murine hematopoietic cells.
Schneider E; Ihle JN; Dy M
Lymphokine Res; 1985; 4(2):95-102. PubMed ID: 3923277
[TBL] [Abstract][Full Text] [Related]
27. Conditioned medium from primary porcine endothelial cells alone promotes the growth of primitive human haematopoietic progenitor cells with a high replating potential: evidence for a novel early haematopoietic activity.
Davis TA; Black AT; Kidwell WR; Lee KP
Cytokine; 1997 Apr; 9(4):263-75. PubMed ID: 9112335
[TBL] [Abstract][Full Text] [Related]
28. [In vivo effect of etoposide on the function of bone marrow-derived macrophages].
Nakanishi M; Sone S; Inamura N; Mahendra SS; Shimizu E; Ogura T
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3237-41. PubMed ID: 2675770
[TBL] [Abstract][Full Text] [Related]
29. T-helper-2 lymphocytes as a peripheral target of melatonin.
Maestroni GJ
J Pineal Res; 1995 Mar; 18(2):84-9. PubMed ID: 7629695
[TBL] [Abstract][Full Text] [Related]
30. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.
Young MR; Newby M; Wepsic HT
Cancer Res; 1987 Jan; 47(1):100-5. PubMed ID: 2947676
[TBL] [Abstract][Full Text] [Related]
31. kappa-Opioid receptors in marrow stroma mediate the hematopoietic effects of melatonin-induced opioid cytokines.
Maestroni GJ
Ann N Y Acad Sci; 1998 May; 840():411-9. PubMed ID: 9629267
[TBL] [Abstract][Full Text] [Related]
32. [Clonogenic stromal cell count in the bone marrow of mice].
Latsinik NV; Gorskaia IuF; Pavlenko RG; Fridenshteĭn AIa
Biull Eksp Biol Med; 1986 Apr; 101(4):468-71. PubMed ID: 3697495
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic effect of melatonin involvement of type 1 kappa-opioid receptor on bone marrow macrophages and interleukin-1.
Maestroni GJ; Zammaretti F; Pedrinis E
J Pineal Res; 1999 Oct; 27(3):145-53. PubMed ID: 10535763
[TBL] [Abstract][Full Text] [Related]
34. Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.
McGary CT; Miele ME; Welch DR
Am J Pathol; 1995 Dec; 147(6):1668-81. PubMed ID: 7495292
[TBL] [Abstract][Full Text] [Related]
35. Effects of endotoxin on murine erythropoiesis in vitro: role of marrow adherent cells.
Anagnostou A; Pololi-Anagnostou L; Schade S
J Reticuloendothel Soc; 1982 Feb; 31(2):145-54. PubMed ID: 7062318
[TBL] [Abstract][Full Text] [Related]
36. [Differential induction of natural suppressor activity of bone marrow cells in vitro by various types of tumors].
Bel'skiĭ IuP; Zemlianskaia NV; Kusmartsev SA; Agranovich IM
Biull Eksp Biol Med; 1995 Aug; 120(8):184-7. PubMed ID: 7579281
[No Abstract] [Full Text] [Related]
37. Thy 1.2+ leukemia cells eradicated from in vitro leukemia-bone marrow cell mixtures by antibody-toxin conjugates.
Colombatti M; Colombatti A; Blythman HE; Bron C
J Natl Cancer Inst; 1984 May; 72(5):1095-9. PubMed ID: 6585586
[TBL] [Abstract][Full Text] [Related]
38. The use of long-term bone marrow cultures (LTBMC) to detect hematotoxic side effects of purging methods.
Schulze E; Helbig W; Hofmann U
Haematol Blood Transfus; 1989; 32():46-50. PubMed ID: 2696690
[TBL] [Abstract][Full Text] [Related]
39. Adherent cells from mouse bone marrow inhibit the formation of colony stimulating factor (CSF) induced myeloid colonies.
Zipori D; Sasson T
Exp Hematol; 1980 Jul; 8(6):816-7. PubMed ID: 7202585
[No Abstract] [Full Text] [Related]
40. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
